140 related articles for article (PubMed ID: 9001344)
1. Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus.
Kinugasa S; Tachibana M; Hishikawa Y; Abe S; Yoshimura H; Monden N; Dhar DK; Nagasue N
Jpn J Clin Oncol; 1996 Dec; 26(6):405-10. PubMed ID: 9001344
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of PCNA expression in laryngeal cancer.
Saraç S; Ayhan A; Hosal AS; Kaya S
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1321-4. PubMed ID: 9865753
[TBL] [Abstract][Full Text] [Related]
4. PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.
Morisaki Y; Shima S; Yoshizumi Y; Sugiura Y; Tanaka S; Tamai S
Surg Today; 1995; 25(5):389-95. PubMed ID: 7640465
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the PC10 index for patients with stage II and III oesophageal cancer treated with radiotherapy.
Sugahara S; Ohara K; Takahashi A; Irie T; Watanabe T; Tanaka N; Nozawa K; Nakajima K; Itai Y
Acta Oncol; 1999; 38(8):1057-62. PubMed ID: 10665763
[TBL] [Abstract][Full Text] [Related]
6. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
7. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus.
Dabrowski A; Szumiło J; Brajerski G; Wallner G
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():59-67. PubMed ID: 11977365
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma.
Ikeguchi M; Ikeda M; Tatebe S; Maeta M; Kaibara N
Oncol Rep; 1998; 5(5):1185-9. PubMed ID: 9683832
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
[TBL] [Abstract][Full Text] [Related]
13. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of proliferating cell nuclear antigen (PCNA) expression in 24 cases of primary non-small cell pulmonary carcinomas and correlation with survival].
Castellano VM; Sotelo T; Ballestín C; López-Encuentra A; Varela G
Arch Bronconeumol; 1996 Mar; 32(3):127-31. PubMed ID: 8634790
[TBL] [Abstract][Full Text] [Related]
17. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
18. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772
[TBL] [Abstract][Full Text] [Related]
19. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
Lu EM; Ratnayake J; Rich AM
BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
